Journals / Cukurova Medical Journal / 2014 / Cilt: 39 - Sayı: 1

Intravesical BCG immunotherapy: Sepsis and multiorgan failure developed after traumatic catheterization

Mesane içi BCG immünoterapisi: Travmatik kateterizasyon sonrası gelişen sepsis ve çoklu organ yetmezliği

Pages
131–136
Publication Date
2014-07-22
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We report a case who died from severe complications such as sepsis, pneumonia, renal failure and granulomatous hepatitis after receiving the first maintanence installation of intravesical BCG immunotherapy for bladder transitional cell carcinoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:İntravesical Bacillus Calmette-Guerin (BCG) instillation is a prophylactic therapy using for treating bladder cancer to prevent tumour progression and recurrence.
📊
Key Findings & Data:Although local complications are common , this therapy is generally well tolerated.
💡
Conclusion & Impact:We report a case who died from severe complications such as sepsis, pneumonia, renal failure and granulomatous hepatitis after receiving the first maintanence installation of intravesical BCG immunotherapy for bladder transitional cell carcinoma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Basillus Calmette-Guerin · çoklu organ yetmezliği · hepatik granülomlar

Abstract

İntravesical Bacillus Calmette-Guerin (BCG) instillation is a prophylactic therapy using for treating bladder cancer to prevent tumour progression and recurrence. Both local and systemic complications can arise after the installation. Although local complications are common , this therapy is generally well tolerated. Systemic complications are rarely than local complications but can be fatal. We report a case who died from severe complications such as sepsis, pneumonia, renal failure and granulomatous hepatitis after receiving the first maintanence installation of intravesical BCG immunotherapy for bladder transitional cell carcinoma.

Özet

Mesane içi Bacillus Calmette-Guerin (BCG) ile immünterapi mesane kanserlerinde, nüksü ve progresyonu önlemek için profilaktik olarak uygulanmaktadır. Uygulama sonrasında lokal ve sistemik yan etkiler ortaya çıkabilir. Lokal yan etkilere sıklıkla rastlanmasına rağmen genel olarak bu tedavi şekli hastalar tarafından iyi tolere edilir. Sistemik yan etkilere daha az rastlanırken fatalite çok nadirdir. Bu yazıda; mesane karsinomu nedeniyle idame mesane içi BCG uygulanmasından sonra ateş, sepsis, pnömoni, akut böbrek yetmezliği, granülamatöz hepatit gelişen ve yoğun bakım ünitesinde exitus ile sonuçlanan olguyu sunduk.

🔖

Cite This Article

ÇİÇEK, T., TOGAN, T., ERİNANÇ, H., UĞUR, M., GÖNÜLALAN, U., ÇİFCİ, E. (2014). Intravesical BCG immunotherapy: Sepsis and multiorgan failure developed after traumatic catheterization. Cukurova Medical Journal, Cilt: 39 - Sayı: 1, 131–136. https://ajindex.com/articles/57048

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Ro JY, Staerkel GA, Ayala AG. Cytologic and histological features of superficial bladder cancer. Urol Clin North Am. 1992;19: 435-53.
  2. Chade DC, Shariat SF, Dalbagni G. İntarvesical Therapy for urothelial Carcinoma of the Urinary Bladder: A Critical Review. Int Braz J Urol. 2009;35:640-50.
  3. Fradet V, Gaudereu C, Perrotte P, Côte J, Paquin JM. Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancer Can Urol Asossc J. 2007;1: 269-72.
  4. Leebeck FW, Ouwendijk RJ, Kolk AH, Dees A, Meek JC, Nienhuis JE, Dingemans-Dumas AM. Granulamatous hepatitis caused by Bacillus Calmette-Guerin(BCG) infection after BCG bladder instillation. Gut. 1996;38:616-8. M.Manohan. Intravesical therapy for urothelial carcinoma of bladder. Indian J Urol. 2011;27:252-61.